Leading Oncologist – Breast and Urological Cancer
Position: Director of the Oncology Hospitalization Department at the Davidoff Cancer Center
Hospital: Rabin Medical Center in Petah Tikva
Prof. Schachter is in the Forbes list of the best Israeli doctors
Qualified Medical Consultation Online, Second Opinion
Qualified Medical Consultation of Dr. Victoria Neiman
- Urological Oncology: Doctor Neiman has conducted extensive research on the treatment and management of prostate, bladder, and kidney cancers. Her work often explores advanced radiotherapy techniques and their effectiveness in improving patient outcomes.
- Breast Cancer: Dr. Neiman has contributed significantly to the field of breast cancer, investigating new treatment protocols and the role of radiotherapy in reducing recurrence rates. Her studies often aim to enhance the precision and efficacy of cancer treatments.
- Radiotherapy Innovations: The doctor is known for her research on innovative radiotherapy methods, including the use of cutting-edge technology to target tumors more accurately while minimizing damage to surrounding healthy tissues.
- Clinical Trials: Dr. Neiman has been involved in numerous clinical trials, testing new drugs and treatment combinations to find more effective solutions for cancer patients.
Send Your Medical Files Book Consultation Now
Medical Expertise
- Breast Cancer and Oncological Urology, with over 30 years of experience.
- Dr. Neiman’s areas of expertise include internal medicine, clinical oncology (with extensive practice in
uro-oncology and breast cancer) and radiotherapy. - She did her residency in Israel at the Rabin Medical Center.
Professional Experience of Dr. Neiman
- Director of the oncology hospitalization department at the Davidoff Cancer Center in the
Rabin Medical Center - Senior doctor in the oncology department at the Tel Aviv Medical Center
- Oncology specialist at Maccabi Health Services, Petah Tikva
Scientific Research and Treatment Discoveries
Dr. Victoria Neiman conducted and is a partner in many studies in the field of clinical oncology, many of them in the fields of the breast, kidneys, urinary system and prostate. Here are a few examples:
- Cost-Effectiveness Analysis of Nivolumab and Ipilimumab Versus Sunitinib: This study evaluated the cost-effectiveness of nivolumab and ipilimumab compared to sunitinib for first-line treatment of advanced renal cell carcinoma. The study found that the combination of nivolumab and ipilimumab was cost-effective, offering a significant survival advantage¹.
- Clinical Outcomes and Response to Vericiguat: This trial, part of the VICTORIA study, focused on patients with heart failure and reduced ejection fraction. It assessed the efficacy and safety of vericiguat, a novel therapy, and provided insights into clinical characteristics and outcomes².
These trials highlight Dr. Neiman’s contributions to advancing cancer treatment and improving patient outcomes.
(1) Cost‐Effectiveness Analysis of Nivolumab and Ipilimumab Versus …. https://academic.oup.com/oncolo/article/24/3/366/6439109.
(2) Home – Clinical Trials and Research. https://www.clinicaltrialsandresearch.vic.gov.au/.
Membership in Professional Associations
- Association for Clinical Oncology and Radiotherapy
- The Israeli Association for Internal Medicine
- The Israeli Association of Urologists
- ESMO
